Search clinical trials for: rhIL-2

Total 47940 results

E25Bio, Inc.
SCRI Development Innovations, LLC

Completed

A Clinical Evaluation of COVID-19 Rapid Point of Care Antigen Tests

SARS CoV-2

United States
Philipps University Marburg Medical Center

Completed

Do Videos That Aim to Optimize Expectations Alter the Effectivess of PMR?

Control Group | Experimental Group 1 (Video Personal Expert) | Experimental Group 2 (Video Factual Expert)

Germany
Universidad de la Republica
Hospital Italiano de Buenos Aires; KU Leuven

Withdrawn

Telemonitoring of Uncontrolled Hypertension (ERNESTINA)

Hypertension

Argentina, Uruguay
ModernaTX, Inc.

Recruiting

Study to Evaluate the Safety, Reactogenicity, and Effectiveness of mRNA-1273.214 SARS-CoV-2 (COVID-19) Vaccine in Infants (BabyCOVE)

SARS-CoV-2

United States
University of Erlangen-Nürnberg Medical School

Recruiting

SARS-CoV2 Antibodies in Pediatric Patients (COVID-19) (SARS-CoV2_KIDS)

SARS-Cov2

Germany
Universitair Ziekenhuis Brussel

Recruiting

SARS-COV-2 Seroprevalence and Seroconversion Among Employees of the Universitair Ziekenhuis Brussel During the 2020 COVID-19 Outbreak (COVEMUZ)

Sars-CoV2

Belgium
ModernaTX, Inc.

Completed

A Study to Evaluate Safety and Effectiveness of mRNA-1273 COVID-19 Vaccine in Healthy Children Between 6 Months of Age and Less Than 12 Years of Age

SARS-CoV-2

United States, Canada
Glycovax Pharma Inc.
Government of Canada; JSS Medical Research Inc.; Seppic; Avance Clinical Pty Ltd.

Active, not recruiting

Safety and Immunogenicity of Glycovax-002 Vaccine in Healthy Adults

SARS-CoV-2

Australia
Genexine, Inc.

Completed

Safety and Immunogenicity of GX-19N, a COVID-19 Preventive DNA Vaccine in Elderly Individuals

SARS-CoV-2

Korea, Republic of
Centre Hospitalier Universitaire de Besancon

Active, not recruiting

Medium and Long Term Follow-up of COVID-19 Infected Patients: Research and Characterization of Pulmonary Sequelae (COV-RECUP)

Sars-CoV2

France
Institut National de la Santé Et de la Recherche...

Completed

Health, Perception, Practices, Relations and Social Inequalities in the General Population During the Covid-19 Crisis (SAPRIS-SERO)

SARS-CoV 2

France
ModernaTX, Inc.

Completed

A Study to Evaluate the Immunogenicity and Safety of mRNA Vaccine Boosters for SARS-CoV-2 (COVID-19) Variants

SARS-CoV-2

United States
Instituto Nacional de Cancerologia de Mexico
Roche Pharma AG

Active, not recruiting

Tocilizumab Treatment in Patients With COVID-19

Sars-CoV2

Mexico
Ology Bioservices
Enabling Biotechnologies (EB)

Completed

Study of Monoclonal Antibody Cocktail Being Tested for the Prevention of COVID-19

SARS-CoV-2

United States
ModernaTX, Inc.

Terminated

Moderna COVID-19 Vaccine mRNA-1273 Observational Pregnancy Outcome Study

SARS-CoV-2

United States
Direction Centrale du Service de Santé des Armées

Completed

SARS-CoV2 (COVID-19) Diagnosis in Human Saliva by MALDI-TOF MS Profiling (CoviDiagMS)

SARS-CoV 2

France
ModernaTX, Inc.

Completed

A Study to Evaluate Safety, Reactogenicity, and Immunogenicity of mRNA-1283 and mRNA-1273 Vaccines in Healthy Adults Between 18 Years and 55 Years of Age to Prevent COVID-19

SARS-CoV-2

United States
IRCCS San Raffaele Roma

Completed

COVID-19 Epidemiological Surveillance on Healthcare Workers and Patients in a Rehabilitation Medicine Facility (COVID-19)

SARS-Cov2

Italy
Johns Hopkins University
National Institute of Allergy and Infectious Diseases (NIAID); United States... and other collaborators

Completed

Convalescent Plasma to Limit SARS-CoV-2 Associated Complications (CSSC-004)

SARS-CoV 2

United States
ModernaTX, Inc.
Biomedical Advanced Research and Development Authority

Completed

Dose-Confirmation Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1273 COVID-19 Vaccine in Adults Aged 18 Years and Older

SARS-CoV-2

United States
Fondazione Epatocentro Ticino

Active, not recruiting

Methylene Blue Treatment of COVID-19

SARS-CoV2

Switzerland
Assistance Publique - Hôpitaux de Paris

Completed

Study of Seroprevalence of Anti-SARS-CoV2 Among Children of Hospital Workers in AP-HP (FamilyPEDCOVID)

SARS-CoV2

France
Centre Hospitalier Universitaire de Besancon

Completed

Study of Viral Load and Maternal-fetal Serology in the Interpretation of the Vertical Transmission of SARS Cov-2 (COVID-19) During Pregnancy (TRANSCOVID)

Sars-CoV2

France
Direction Centrale du Service de Santé des Armées

Completed

Study of SARS-CoV2 Virus (COVID-19) Seroprevalence in the Population of Creil Air Force Base (BA110) (EpiCovCreil)

Sars-CoV2

France
Centre Hospitalier Universitaire Vaudois

Completed

Dry Versus Wet Nasopharyngeal Rapid Test for the Detection of COVID-19. (RESTART)

SARS-CoV-2

Switzerland
Direction Centrale du Service de Santé des Armées

Completed

Study of the SARS-COV-2 (COVID-19) Serological Profile of an Army Training Hospital Staff (SEROSARSCOV)

Sars-CoV2

France
Latin American Cooperative Oncology Group
Oncoclínicas

Withdrawn

HOPE: A Trial of Hydroxichloroquine Plus Azithromycin in High Risk COVID-19 (HOPE_BRAZIL)

Sars-CoV2

Brazil
Eisai Inc.
Merck Sharp & Dohme LLC

Completed

A Trial of Lenvatinib (E7080) in Subjects With Iodine-131 Refractory Differentiated Thyroid Cancer to Evaluate Whether an Oral Starting Dose of 18 Milligram (mg) Daily Will Provide Comparable Efficacy to a 24 mg Starting Dose, But Have a Better Safety Profile

Thyroid Cancer

United States, Canada, Germany, Korea, Republic of, Spain, France, Australia, Belgium, Denmark, Israel, Italy, Poland, Romania, Russian Federation, Sweden, United Kingdom
Chong Kun Dang Pharmaceutical

Completed

CKD-828 (80/5mg) Pharmacokinetic Study (CKD-828)

Hypertension

Korea, Republic of
Chong Kun Dang Pharmaceutical

Completed

CKD-828 (80/5mg) Pharmacokinetic Study

Hypertension

Korea, Republic of
Memorial Sloan Kettering Cancer Center
National Institutes of Health (NIH)

Recruiting

Testing a New Imaging Agent to Identify Cancer

HER2-positive Metastatic Breast Cancer | HER-2 Protein Overexpression | HER-2 Positive Malignant Carcinoma of Breast

United States
University of Kansas Medical Center
National Institute on Aging (NIA)

Completed

Dementia Risk and Dynamic Response to Exercise (DYNAMIC)

Healthy Aging | Alzheimer Disease 2 Due to Apoe4 Isoform

United States
Shanghai Pulmonary Hospital, Shanghai, China

Recruiting

Cadonilimab Plus Chemotherapy as First-line Treatment for PD-L1 Negative NSCLC (LungCadX)

NSCLC

China
Johannes Gutenberg University Mainz

Recruiting

Mainz Intracoronary Database. The Coronary Slow-flow and Microvascular Diseases Registry (MICAT)

Coronary Artery Disease | Microvascular Dysfunction

Germany
Novartis Pharmaceuticals

Completed

Effect of the Fixed Dose Combination Amlodipine/Valsartan on Central Aortic Blood Pressure in Uncontrolled Essential Hypertension With Amlodipine 5 mg (EXPLOR)

Hypertension

France
Gerencia De Atencion Primaria Area 2 De Madrid
Health Research Fund of ISCIII Spain

Completed

Development, Implementation and Evaluation of the Impact of a Guideline in Clinical Practise for Cardiovascular Risk

Cardiovascular Risk Factors | Primary Care | Clinical Practice Guideline | Implementation Strategies

Spain
Sichuan Academy of Medical Sciences

Recruiting

Dapagliflozin Delays the Loss of Renal Function in Peritoneal Dialysis Patients

Peritoneal Dialysis Complication | Renal Function Aggravated | Sodium-glucose Co-transporter-2 Inhibitors

China
AIM Vaccine Co., Ltd.
Ningbo Rongan Biological Pharmaceutical Co. Ltd.; LiveRNA Therapeutics Inc.; AIM...

Recruiting

A Global Multi-center Clinical Study of SARS-CoV-2 mRNA Vaccine for the Prevention of COVID-19

SARS-CoV-2

Kenya
ModernaTX, Inc.

Recruiting

A Study to Evaluate the Safety and Immunogenicity of the mRNA COVID-19 Vaccines in Healthy Children Between 6 Months to Less Than 6 Years of Age

SARS-CoV-2

United States, Puerto Rico, Panama
University of Pennsylvania

Not yet recruiting

ACE2 Chewing Gum on SARS-CoV-2 Viral Load (COVID 19)

SARS-CoV-2

United States
University Hospital, Lille

Recruiting

Rapid Detection of COVID-19 by Portable and Connected Biosensor (COR-DIAL-1)

Sars-CoV2

France
AstraZeneca

Completed

AZD7442 Pharmacokinetics, Pharmacodynamics, and Safety Evaluation in Pediatrics (TRUST)

SARS-CoV-2

United States, Belgium, United Kingdom, Brazil, Germany
Centre Hospitalier Saint Joseph Saint Luc de Lyon

Completed

Serological Study of the Exposure of Personnel to COVID-19 (SEROPHUGAC)

Sars-CoV2

France
ModernaTX, Inc.
Aetion, Inc.

Active, not recruiting

Post-marketing Safety of Elasomeran/Davesomeran and Andusomeran

SARS-CoV-2

United States
Entos Pharmaceuticals Inc.
Canadian Institutes of Health Research (CIHR); Aegis Life, Inc.; Clinical Pharma... and other collaborators

Completed

A Clinical Trial of a Prophylactic Plasmid DNA Vaccine for COVID-19 [Covigenix VAX-001] in Adults

SARS-CoV-2

Burkina Faso, Canada, Senegal, South Africa
Yale University

Completed

Colchicine/Statins for the Prevention of COVID-19 Complications (COLSTAT) Trial (COLSTAT)

SARS-CoV-2

United States
AIM Vaccine Co., Ltd.
First Affiliated Hospital Bengbu Medical College; Ningbo Rongan Biological...

Active, not recruiting

A Preliminary Exploratory Cohort Study of COVID-19 mRNA Vaccine, Bivalent in Participants Aged 18 Years and Over in China

SARS-CoV-2

China
Convergent Genomics, Inc.

Completed

Comparison of EPM-IX to Currently Used Specimen Transportation and Extraction Devices ( CGI-EPM-IX ) (CGI-EPM-IX)

SARS-CoV-2

United States
ModernaTX, Inc.

Completed

A Study to Compare mRNA-1273 Versus BNT162b2 COVID-19 Vaccines Among Immunocompromised Adults

SARS-CoV-2

United States
Illumina, Inc.
Helix OpCo, LLC

Completed

Evaluation of the COVIDSeq Test in Nasal Swab and Saliva From a COVID-19 Asymptomatic Population

SARS-CoV-2

United States

Search clinical trials for: rhIL-2

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Australia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations